Neuromidine - instructions for use, analogs, reviews and release forms (20 mg tablets, injections in injections) drugs for paresis, paralysis and polyneuropathy in adults, children and pregnancy. Interaction with alcohol
In this article, you can read the instructions for using the drug Neuromidine. There are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors of specialists on the use of Neuromidine in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Neurromidine in the presence of existing structural analogues.Use for the treatment of paresis, paralysis and polyneuropathies in adults, children, as well as during pregnancy and lactation. Interaction of the drug with alcohol.
Neuromidine cholinesterase inhibitor. It has a direct stimulating effect on impulse conduction on nerve fibers, interneuronal and neuromuscular synapses of the peripheral and central nervous system. Pharmacological action of the drug Neuromidine is based on a combination of two mechanisms of action: blockade of the potassium channels of the membrane of neurons and muscle cells; reversible inhibition of cholinesterase in synapses.
Neurromidine enhances the effect on the smooth muscles of not only acetylcholine, but also adrenaline, serotonin, histamine and oxytocin.
Neuromidine has the following pharmacological effects: it improves and stimulates the impulse in the nervous system and neuromuscular transmission; strengthens the contractility of smooth muscle organs under the influence of agonists acetylcholine, adrenaline, serotonin, histamine and oxytocin receptors, with the exception of potassium chloride; improves memory, inhibits the progressive course of dementia.
Composition
Ipidacrine hydrochloride (in the form of monohydrate) + auxiliary substances.
Pharmacokinetics
After ingestion, the drug is rapidly absorbed from the digestive tract. After parenteral administration, the drug is also rapidly absorbed. Ipidacrin quickly enters the tissues, the half-distribution period is 40 minutes. Metabolised in the liver. It is excreted by the kidneys, and also extrarenally (through the digestive tract).
Indications
- diseases of the peripheral nervous system: mono- and polyneuropathy, polyradiculopathy, myasthenia gravis, myasthenic syndrome of various etiologies;
- diseases of the central nervous system: bulbar paralysis and paresis; the recovery period of organic lesions of the CNS, accompanied by motor and / or cognitive impairment;
- treatment and prevention of intestinal atony.
Forms of release
Tablets of 20 mg.
Solution for intramuscular and subcutaneous injection (injections in ampoules for injection).
Instructions for use and dosing regimen
Doses and duration of treatment Neuromidin is determined individually, depending on the severity of the disease.
Diseases of the peripheral nervous system: mono- and polyneuropathy, polyradiculopathy, myasthenia gravis, myasthenic syndrome of different etiology - prescribe inside by 10-20 mg (0.5-1 tablets) 1-3 times a day.Parenteral drug is used intramuscularly or subcutaneously at 5-15 mg 1-2 times a day. The course of treatment is from 1 to 2 months. If necessary, the course of treatment can be repeated several times with a break between courses in 1-2 months.
To prevent myasthenic crises in severe disorders of neuromuscular conduction, 1-2 ml (15-30 mg) of 1.5% Neuromidine solution for injections are injected for a short time, then the treatment is continued, prescribing the drug inside in the form of tablets - the dose can be increased to 20-40 mg (1-2 tablets) 5 times a day.
Central nervous system diseases: bulbar paralysis and paresis, recovery period of organic CNS lesions (traumatic, vascular and other genesis), accompanied by motor and / or cognitive impairment - inside by 10-20 mg (0.5-1 tablets) 2-3 times a day. The course of treatment is from 2 to 6 months. If necessary, repeat the treatment.
Treatment and prevention of intestinal atony: inside the drug is prescribed to 20 mg (1 tablet) 2-3 times a day for 1-2 weeks. If the next dose has not been taken on time, in addition it should not be taken.
With parenteral administration, the initial dose of the drug is 10-15 mg per day for 1-2 weeks.The dose of the drug can be increased to 30 mg per day.
The maximum daily dose is 200 mg.
Side effect
- salivation;
- increased sweating;
- palpitation;
- nausea, vomiting;
- diarrhea;
- bradycardia;
- pain in epigastrium;
- increased secretion of bronchial secretions;
- convulsions;
- dizziness;
- headache;
- general weakness;
- drowsiness;
- skin allergic reactions (itching, rash);
- increase in the tone of the uterus.
Contraindications
- epilepsy;
- vestibular disorders;
- extrapyramidal diseases with hyperkinesis;
- angina pectoris;
- severe bradycardia;
- bronchial asthma;
- peptic ulcer of the stomach or duodenum in the phase of exacerbation;
- mechanical obstruction of the intestine or urinary tract;
- pregnancy (the drug raises the tone of the uterus);
- lactation period (breastfeeding);
- children and adolescents under 18 years of age (no systematic data on the application);
- hypersensitivity to the components of the drug.
Application in pregnancy and lactation
Contraindicated use of the drug during pregnancy and lactation (breastfeeding).
The drug does not have teratogenic, embryotoxic effects.
special instructions
During the period of treatment, the patient should exclude the use of alcohol. Alcohol increases the side effects of the drug.
Impact on the ability to drive vehicles and manage mechanisms
During treatment, the patient should refrain from driving motor vehicles, as well as practicing potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.
Drug Interactions
Neuromidine enhances sedation in combination with CNS depressants.
The effect of the drug and side effects are enhanced when combined with other cholinesterase inhibitors and m-cholinomimetic agents.
In patients with myasthenia gravis, the risk of developing a cholinergic crisis increases with the simultaneous use of Neuromidine with other cholinergic agents.
The risk of bradycardia increases if beta-blockers were used before the start of treatment with Neuromidine.
The drug can be used in combination with nootropic drugs.
Ethanol (alcohol) increases the side effects of the drug.
Neuromidine weakens the depressing effect on neuromuscular transmission and conduction of excitation along the peripheral nerves of local anesthetics, aminoglycosides, potassium chloride.
Analogues of the drug Neuromidine
Structural analogs for the active substance:
- Aksamon;
- Amiridin 20 mg.
Similar medicines:
Other medicines:
- Rotokan - instructions for use, analogs, reviews and release forms (extract or solution Vilar) for inhalation and mouth and throat rashes for stomatitis and angina in adults, children and pregnancy. Composition
- Vikasol - instructions for use, reviews, analogs and forms of release (15 mg tablets, injections in injections) of a drug for the treatment of heavy bleeding (including those with menstruation) in adults, children and pregnancy
- Efferlangan - instructions for use, testimonials, analogues and forms of release (suppositories 80 mg, 150 mg and 300 mg, tablets effervescent 500 mg of UFSA and with vitamin C, children's syrup, solution 3%) drugs for pain in adults, children and pregnancy. Composition